1B1 Stock Overview
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
HC Surgical Specialists Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.27 |
52 Week High | S$0.48 |
52 Week Low | S$0.24 |
Beta | 0.075 |
1 Month Change | -8.47% |
3 Month Change | -8.47% |
1 Year Change | -22.86% |
3 Year Change | -37.93% |
5 Year Change | -54.24% |
Change since IPO | -50.91% |
Recent News & Updates
Recent updates
Shareholder Returns
1B1 | SG Healthcare | SG Market | |
---|---|---|---|
7D | 0% | 0.8% | 1.6% |
1Y | -22.9% | -21.9% | -4.4% |
Return vs Industry: 1B1 matched the SG Healthcare industry which returned -21.9% over the past year.
Return vs Market: 1B1 underperformed the SG Market which returned -4.4% over the past year.
Price Volatility
1B1 volatility | |
---|---|
1B1 Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in SG Market | 14.3% |
10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 1B1 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 1B1's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | Sieu Min Heah | https://www.hcsurgicalspecialists.com |
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal abscesses, anal fissures, anal fistula, gallstones and inflammation of the gallbladder, appendicitis, hernias, gastric and colorectal cancer, colonic diverticular disease, and cysts and lipomas; vein laser vascular, laparoscopy, cholecystitis, and other general and specialized medical services; and orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, carpel tunnel syndrome, wounds/lumps, joint replacement, arthroscopic surgery, and fractures.
HC Surgical Specialists Limited Fundamentals Summary
1B1 fundamental statistics | |
---|---|
Market cap | S$41.53m |
Earnings (TTM) | S$4.32m |
Revenue (TTM) | S$18.91m |
9.6x
P/E Ratio2.2x
P/S RatioIs 1B1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1B1 income statement (TTM) | |
---|---|
Revenue | S$18.91m |
Cost of Revenue | S$9.60m |
Gross Profit | S$9.30m |
Other Expenses | S$4.98m |
Earnings | S$4.32m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.028 |
Gross Margin | 49.20% |
Net Profit Margin | 22.85% |
Debt/Equity Ratio | 12.2% |
How did 1B1 perform over the long term?
See historical performance and comparison